Minimal change disease: A review

被引:21
作者
Saha, Tapasi C. [1 ]
Singh, Harmeet [1 ]
机构
[1] E Carolina Univ, Brody Sch Med, Greenville, NC 27834 USA
关键词
minimal change disease; nephrotic syndrome; proteinuria;
D O I
10.1097/01.smj.0000243183.87381.c2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Minimal change disease (MCD) is a histopathological lesion in the kidney that is most commonly associated with nephrotic syndrome. The majority of the cases are idiopathic. Pathogenesis is not well understood, although T-cell-related mechanisms are implicated. Massive proteinuria leads to hypoalbuminemia, salt retention, disorder of hemostasis, hyperlipidemia and increased susceptibility to infections. Renal biopsy remains the gold standard for diagnosis. MCD is highly responsive to corticosteroids. Other immunosuppressive agents such as cyclophosphamide, cyclosporin, azathioprine and mycophenolate mofetil have been used to treat cases which are resistant to steroids.
引用
收藏
页码:1264 / 1270
页数:7
相关论文
共 50 条
  • [41] Secondary minimal change disease
    Glassock, RJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 : 52 - 58
  • [42] Is edema in minimal change disease of childhood really hypovolemic?
    Yilmaz Tabel
    Ilke Mungan
    Cemsit Karakurt
    Gulendam Kocak
    Serdal Gungor
    International Urology and Nephrology, 2008, 40 : 757 - 761
  • [43] De novo minimal change disease after ABO-incompatible kidney transplantation
    Mochizuki, Yasushi
    Iwata, Takahisa
    Nishikido, Masaharu
    Uramatsu, Tadashi
    Sakai, Hideki
    Taguchi, Takashi
    CLINICAL TRANSPLANTATION, 2012, 26 : 81 - 85
  • [44] Clinical Course of Adult FSGS and Minimal Change Disease in North American and Japanese Cohorts
    Ozeki, Takaya
    Gillespie, Brenda W.
    Larkina, Maria
    Maruyama, Shoichi
    Alakwaa, Fadhl
    Kretzler, Matthias
    Mariani, Laura H.
    KIDNEY360, 2023, 4 (07): : 924 - 934
  • [45] Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease
    Li, Xiao-Wei
    Cheng, Shui-Qin
    Liang, Shao-Shan
    Le, Wei-Bo
    Zeng, Cai-Hong
    Wang, Jin-Quan
    Liu, Zhi-Hong
    CLINICAL NEPHROLOGY, 2016, 85 (05) : 273 - 280
  • [46] Rituximab for Steroid-Dependent Minimal Change Disease in Adults: Is It Time for a Change?
    Kannan, Lakshmi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [47] Kimura Disease Associated with Minimal Change Disease
    Eren, Rafet
    Comert, Enes
    Mansuroglu, Ilknur
    Dogan, Esma Evrim
    Kadioglu, Gulay
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (02) : 165 - 166
  • [48] Minimal change disease following COVID-19 vaccination: A systematic review
    Kechagias, Konstantinos S.
    Laleye, Joshua D.
    Drmota, Jan
    Geropoulos, Georgios
    Kyrtsonis, Georgios
    Zafeiri, Marina
    Triantafyllidis, Konstantinos Katsikas
    Stathi, Dimitra
    PLOS ONE, 2024, 19 (03):
  • [49] Minimal change disease induced by tiopronin: a rare case report and a review of the literature
    Zhong, Han
    Wang, Ling
    Gu, Zhi-Chun
    Cui, Min
    Liu, Xiao-Yan
    Pang, Xiao-Yun
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (16)
  • [50] Emerging role of Rituximab in adult minimal change disease: a narrative review of clinical evidence, biomarkers and future perspectives
    Zhong, Anni
    Yu, Yi
    Cao, Tao
    Wan, Qijun
    Xu, Ricong
    BMC NEPHROLOGY, 2025, 26 (01)